| |
|
|
|
|
|
|
|||
|
Blood, 15 November 2007, Vol. 110, No. 10, pp. 3582-3590. Prepublished online as a Blood First Edition Paper on July 16, 2007; DOI 10.1182/blood-2007-01-070391.
HEMATOPOIESIS The Shc-binding site of the βc subunit of the GM-CSF/IL-3/IL-5 receptors is a negative regulator of hematopoiesis1 Cytokine Receptor Laboratory, Division of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, Australia; 2 Cell Growth and Differentiation Laboratory, Division of Human Immunology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, Australia; 3 Department of Medicine, University of Adelaide, Adelaide, Australia; 4 Department of Biochemistry and Molecular Biology, Monash University, Victoria, Australia; and 5 Amgen, Thousand Oaks, CA
Tyrosine and serine phosphorylation of the common β chain (βc) of the granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and IL-5 receptors is widely viewed as a general mechanism that provides positive inputs by coupling the receptor to signaling pathways that stimulate several cellular functions. We show here that despite the known action of Tyr577 in βc to recruit Shc–PI-3 kinase (PI3K) pathway members, Tyr577 plays, surprisingly, a negative regulatory role in cell function, and that this is mediated, at least in part, through the uncoupling of SH2-containing inositol 5'-phosphatase (SHIP) from βc. Fetal liver cells from βc/βIL-3–/– mice expressing human GM-CSF receptor
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2007 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||